CAR T-cell therapy approved in China for large B-Cell lymphoma treatment 04/09/2021 Bristol Myers Squibb’s CAR-T drug Breyanzi has a sister med on the market.
First CAR T-Cell therapy approved in China 24/06/2021 The novel CAR T-cell therapy – Yescarta from Fosun Kite has recently been approved by the National Medical Products Administration (NMPA) in China.